Physician profile
Rintaro Hashimoto
NPI 1780318501
$944.71
in general payments reported to CMS, 2019-2025
4 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $799 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $689 · Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $689.04 |
| Food and Beverage | $255.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ovesco Endoscopy USA, INC. | $689.04 | 2023 | |
| Laborie Medical Technologies Corp. | $126.59 | 2025 | Alphaone |
| Endogastric Solutions, INC | $109.57 | 2023 | Esophyx |
| Olympus America INC. | $19.51 | 2025 | Visiglide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rintaro Hashimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.